540-18-020 Asbestos and Hazmat Testing Report.pdf

ASBESTOS & HAZMAT TESTING REPORT FOR 50% DD SUBMISSION

CLARKSBURG VA MEDICAL CENTER, CLARKSBURG, WV

RENOVATE PHARMACY FOR USP COMPLIANCE - BLDG. 1

VA PROJECT 540-18-020

SEPTEMBER 2024

Date: September 27, 2024

Items: Summary Results of Asbestos/HazMat Survey, Visual Inspection, Lab Results

Inspector: Brett Brumbaugh, Castle Hill Associates

BUILDING 1

ASBESTOS MATERIALS IN WORK AREAS

There were no asbestos containing materials in the work areas which will be impacted by the planned renovations.

LEAD-BASED PAINT & LEAD COMPONENTS IN WORK AREAS

There were no components painted with lead-based paint or coated components with lead identified in the renovation work areas.

CLARKSBURG VA MEDICAL CENTER, CLARKSBURG, WV - RENOVATE PHARMACY FOR USP COMPLIANCE - BLDG. 1

ASBESTOS & HAZMAT TESTING REPORT

LOCATION:

CLARKSBURG VA MEDICAL CENTER

1 MEDICAL CENTER DR.

CLARKSBURG, WV 26301

PROJECT:

RENOVATE PHARMACY FOR USP COMPLIANCE

VA PROJECT #: 540-18-020

SAMPLING DATE:

SEPTEMBER 21, 2024

CONSULTANT:

CASTLE HILL ASSOCIATES, LLC

1197 FARNSWORTH RD., UNIT E

WATERVILLE, OH 43566

567-952-0212 www.CASTLEHILLASSOCIATES.com

CLARKSBURG VA MEDICAL CENTER, CLARKSBURG, WV

RENOVATE PHARMACY FOR USP COMPLIANCE - BLDG. 1

Date: September 27, 2024

Items: Summary Results of Asbestos/HazMat Survey, Visual Inspection, Lab Results

Inspector: Brett Brumbaugh, Castle Hill Associates

ASBESTOS MATERIALS IN WORK AREAS

There were no asbestos containing materials in the work areas which will be impacted by the planned renovations.

LEAD-BASED PAINT & LEAD COMPONENTS IN WORK AREAS

identified in the renovation work areas.

TABLE OF CONTENTS

• ASBESTOS & LEAD PAINT SAMPLING SUMMARY

• ABESTOS BULK SAMPLING DESCRIPTIONS AND LAB RESULTS

• LEAD SAMPLING DESCRIPTIONS AND RESULTS

• ASBESTOS LABORATORY REPORT

• LEAD XRF TESTING DATA REPORT

• INSPECTOR & ASBESTOS LABORATORY CERTIFICATION

• WORK AREA DRAWINGS

ASBESTOS & HAZMAT TESTING SUMMARY

On September 21, 2024, Brett Brumbaugh performed asbestos and lead-based paint testing in Building 1 at the Clarksburg VA Medical Center in Clarksburg, WV in preparation of the renovations to the building for the project to renovate the Pharmacy for USP Compliance.

ASBESTOS INSPECTION FINDINGS

As a result of this inspection, testing, and laboratory analyses, it has been determined that there is no asbestos containing materials in the work areas which will be impacted by the planned renovations.

LEAD-BASED PAINT & LEAD COMPONENTS

identified in the areas affected by the renovations or addition.

Inspector, Brett L. Brumbaugh, REPA, CESCO West Virginia Licensed Asbestos Inspector EPA Licensed Lead Paint Risk Assessor

SEPTEMBER 2024 ASBESTOS TESTING DATA

Site: Clarksburg VA Medical Center Location: Clarksburg, WV Project Name: Renovate Pharmacy for USP Compliance - Bldg. 1 Sampling Date: September 21, 2024 Sampler: Brett Brumbaugh

Certification: WV Licensed Asbestos Inspector # AI010074 Analysis Date: September 26, 2024

Laboratory: Eurofins - Norcross, GA

SAMPLE

HA # MATERIAL AREA/LOCATION

LABORATORY

RESULT

1 A 12” pink floor tile and mastic Hall at B215c Mech. Room No Asbestos Detected

2 A 12” pink floor tile and mastic Hall at B215c Mech. Room No Asbestos Detected

3 B White mastic on fiberglass insul. B215c Mech. Room No Asbestos Detected

4 B White mastic on fiberglass insul. B215c Mech. Room No Asbestos Detected

5 C Drywall mud/joint compound B215c Mech. Room No Asbestos Detected

6 C Drywall mud/joint compound B215c Mech. Room No Asbestos Detected

7 C Drywall mud/joint compound Mech. Room B218 No Asbestos Detected

8 D 2x2 lay-in ceiling tile Mech. Room B218 No Asbestos Detected

9 D 2x2 lay-in ceiling tile Hall at B215c Mech. Room No Asbestos Detected

10 E Drywall board B215c Mech. Room No Asbestos Detected

11 E Drywall board Mech. Room B218 No Asbestos Detected

12 F Black tar waterproofing on wall Storage Room B243 No Asbestos Detected

13 F Black tar waterproofing on wall Storage Room B243 No Asbestos Detected

14 G 12” tan floor tile and mastic Office 645 No Asbestos Detected

15 G 12” tan floor tile and mastic Office 645 No Asbestos Detected

16 H Brown cove base and mastic Office 645 No Asbestos Detected

17 H Brown cove base and mastic Office 645 No Asbestos Detected

18 I Ceramic wall tile grout Office 645 restroom No Asbestos Detected

19 I Ceramic wall tile grout Office 645 restroom No Asbestos Detected

20 J 2x2 lay-in ceiling tile Office 645 No Asbestos Detected

21 J 2x2 lay-in ceiling tile Office 645 No Asbestos Detected

22 K Roof tar on concrete deck Roof above office 645 under rubber No Asbestos Detected

23 K Roof tar on concrete deck Roof above office 645 under rubber No Asbestos Detected

LEAD XRF TESTING DATA

Project: Clarksburg VA Medical Center

Location: Clarksburg, WV

Area: Renovate Pharmacy for USP Compliance - Bldg. 1

Inspector: Brett Brumbaugh

Date: 9/21/2024

XRF: Viken Detection

Model: Pb200i XRF Lead Paint Analyzer - SN 2757

Reading # Room/Area Component Paint/Component

Color Pb Conc.

mg/cm2

Result

1 B215D Wall White 0.0 Negative

2 B215D Door frame White 0.0 Negative

3 B215C Door frame Pink 0.0 Negative

4 B215C Door Pink 0.0 Negative

5 B215C Drywall wall White 0.0 Negative

6 B215C Drywall wall Tan 0.0 Negative

7 B218 Drywall wall White 0.0 Negative

8 B218B Concrete wall White 0.0 Negative

9 B243 Drywall wall Tan 0.0 Negative

10 B245 Drywall wall White 0.0 Negative

11 Office 545 Drywall wall Tan 0.0 Negative

12 Office 545 Door frame Tan 0.0 Negative

13 Office 545 Door Tan 0.0 Negative

14 Office 545 Roof deck Gray 0.0 Negative

NOTE: Any XRF reading equal to or greater than 1.0 mg/cm2 is considered to be lead-based paint (HUD/EPA)

NOTE: Any XRF reading greater than 0.0 mg/cm2 is considered to be lead-containing paint (OSHA)

PHOTOGRAPHS OF WORK AREAS

Photo 1 Pharmacy Ante Room

Photo 2 Mechanical Room B215C

Photo 3 Storage Room B243

PHOTOGRAPHS OF WORK AREAS

Photo 4 Storage Room B218B

Photo 5 Office 645

Photo 6 Roof above 645

ASBESTOS LAB REPORT

Approved by:

Approved Signatory Alexis Starrett

Report for:

Mr. Brett Brumbaugh, REPA Castle Hill Associates PO Box 283 Waterville, OH 43566

Regarding:

Eurofins EPK Built Environment Testing, LLC Project: Clarksburg VAMC; Renovate Pharmacy For USD

EML ID: 3790025

All samples were received in acceptable condition unless noted in the Report Comments portion in the body of the report. The results relate only to the samples as received and tested. The results include an inherent uncertainty of measurement associated with estimating percentages by polarized light microscopy. Measurement uncertainty data for sample results with >1% asbestos concentration can be provided when requested.

Eurofins EPK Built Environment Testing, LLC ("the Company"), a member of the Eurofins Built Environment Testing group of companies, shall have no liability to the client or the client's customer with respect to decisions or recommendations made, actions taken or courses of conduct implemented by either the client or the client's customer as a result of or based upon the Test Results. In no event shall the Company be liable to the client with respect to the Test Results except for the Company's own willful misconduct or gross negligence nor shall the Company be liable for incidental or consequential damages or lost profits or revenues to the fullest extent such liability may be disclaimed by law, even if the Company has been advised of the possibility of such damages, lost profits or lost revenues. In no event shall the Company's liability with respect to the Test Results exceed the amount paid to the Company by the client therefor.

Dates of Analysis:

Asbestos PLM: 09-26-2024

Service SOPs: Asbestos PLM (EPA 40CFR App E to Sub E of Part 763 & EPA METHOD 600/R-93-116, SOP EM-AS-S-1267) NVLAP Lab Code 201060-0

EMLab ID: 3790025, Page 1 of 7Eurofins EPK Built Environment Testing, LLC

Eurofins EPK Built Environment Testing, LLC 6215 Regency Parkway, Suite 900, Norcross, GA 30071

(866) 871-1984 www.eurofinsus.com/BuiltClient: Castle Hill Associates C/O: Mr. Brett Brumbaugh, REPA Re: Clarksburg VAMC; Renovate Pharmacy For

USD

Date of Sampling: 09-20-2024 Date of Receipt: 09-23-2024 Date of Report: 09-26-2024

ASBESTOS PLM REPORT

Total Samples Submitted: 23 Total Samples Analyzed: 23

Total Samples with Layer Asbestos Content > 1%: 0

Location: 1, 12" Pink FT Lab ID-Version‡: 18693779-1

Sample Layers Asbestos Content Pink Floor Tile ND

Gray Grout ND Yellow Mastic ND

Sample Composite Homogeneity: Moderate

Location: 2, 12" Pink FT Lab ID-Version‡: 18693780-1

Sample Layers Asbestos Content Pink Floor Tile ND

Gray Grout ND Yellow Mastic ND

Sample Composite Homogeneity: Moderate

Location: 3, White Mastic on FG TSI Lab ID-Version‡: 18693781-1

Sample Layers Asbestos Content Silver Foil with White Paper ND

Composite Non-Asbestos Content: 15% Cellulose 5% Glass Fibers

Sample Composite Homogeneity: Good

Location: 4, White Mastic on FG TSI Lab ID-Version‡: 18693782-1

Sample Layers Asbestos Content Silver Foil with White Paper ND

Composite Non-Asbestos Content: 15% Cellulose 5% Glass Fibers

Sample Composite Homogeneity: Good

EMLab ID: 3790025, Page 2 of 7Eurofins EPK Built Environment Testing, LLC

The test report shall not be reproduced except in full, without written approval of the laboratory. The report must not be used by the client to claim product certification, approval, or endorsement by NVLAP, NIST, or any agency of the federal government. The Company reserves the right to dispose of all samples after a period of thirty (30) days, according to all state and federal guidelines, unless otherwise specified.

All components not quantified as asbestos content and non-asbestos content are considered to be non-fibrous matrix components. Matrix components may include, but are not limited to, gypsum, paint, silicate minerals, vinyl, binder, calcium carbonate, tar, and foam.

Inhomogeneous samples are separated into homogeneous subsamples and analyzed individually. ND means no fibers were detected. When detected, the minimum detection and reporting limit is less than 1% unless point counting is performed. Floor tile samples may contain large amounts of interference material and it is recommended that the sample be analyzed by gravimetric point count analysis to lower the detection limit and to aid in asbestos identification.

‡ A "Version" indicated by -"x" after the Lab ID# with a value greater than 1 indicates a sample with amended data. The revision number is reflected by the value of "x".

(866) 871-1984 www.eurofinsus.com/BuiltClient: Castle Hill Associates C/O: Mr. Brett Brumbaugh, REPA Re: Clarksburg VAMC; Renovate Pharmacy For

USD

Date of Sampling: 09-20-2024 Date of Receipt: 09-23-2024 Date of Report: 09-26-2024

ASBESTOS PLM REPORT

Location: 5, Drywall Mud Lab ID-Version‡: 18693783-1

Sample Layers Asbestos Content White Mud with Paint ND

Sample Composite Homogeneity: Good

Location: 6, Drywall Mud Lab ID-Version‡: 18693784-1

Sample Layers Asbestos Content White Mud with Paint ND

Sample Composite Homogeneity: Good

Location: 7, Drywall Mud Lab ID-Version‡: 18693785-1

Sample Layers Asbestos Content White Mud with Paint ND

Sample Composite Homogeneity: Good

Location: 8, 2x2 Ceiling Tile Lab ID-Version‡: 18693786-1

Sample Layers Asbestos Content Off-White Ceiling Tile with White Surface ND

Composite Non-Asbestos Content: 60% Mineral Wool 30% Cellulose

Sample Composite Homogeneity: Good

EMLab ID: 3790025, Page 3 of 7Eurofins EPK Built Environment Testing, LLC

The test report shall not be reproduced except in full, without written approval of the laboratory. The report must not be used by the client to claim product certification, approval, or endorsement by NVLAP, NIST, or any agency of the federal government. The Company reserves the right to dispose of all samples after a period of thirty (30) days, according to all state and federal guidelines, unless otherwise specified.

All components not quantified as asbestos content and non-asbestos content are considered to be non-fibrous matrix components. Matrix components may include, but are not limited to, gypsum, paint, silicate minerals, vinyl, binder, calcium carbonate, tar, and foam.

Inhomogeneous samples are separated into homogeneous subsamples and analyzed individually. ND means no fibers were detected. When detected, the minimum detection and reporting limit is less than 1% unless point counting is performed. Floor tile samples may contain large amounts of interference material and it is recommended that the sample be analyzed by gravimetric point count analysis to lower the detection limit and to aid in asbestos identification.

‡ A "Version" indicated by -"x" after the Lab ID# with a value greater than 1 indicates a sample with amended data. The revision number is

(866) 871-1984 www.eurofinsus.com/BuiltClient: Castle Hill Associates C/O: Mr. Brett Brumbaugh, REPA Re: Clarksburg VAMC; Renovate Pharmacy For

USD

Date of Sampling: 09-20-2024 Date of Receipt: 09-23-2024 Date of Report: 09-26-2024

ASBESTOS PLM REPORT

Location: 9, 2x2 Ceiling Tile Lab ID-Version‡: 18693787-1

Sample Layers Asbestos Content Off-White Ceiling Tile with White Surface ND

Composite Non-Asbestos Content: 60% Mineral Wool 30% Cellulose

Sample Composite Homogeneity: Good

Location: 10, Drywall Board Lab ID-Version‡: 18693788-1

Sample Layers Asbestos Content White Drywall with Brown Paper ND

Composite Non-Asbestos Content: 10% Cellulose Sample Composite Homogeneity: Good

Location: 11, Drywall Board Lab ID-Version‡: 18693789-1

Sample Layers Asbestos Content White Drywall with Brown Paper ND

Composite Non-Asbestos Content: 10% Cellulose Sample Composite Homogeneity: Good

Location: 12, Black Tar on Wall Lab ID-Version‡: 18693790-1

Sample Layers Asbestos Content Black Tar ND Composite Non-Asbestos Content: 5% Cellulose Sample Composite Homogeneity: Good

EMLab ID: 3790025, Page 4 of 7Eurofins EPK Built Environment Testing, LLC

The test report shall not be reproduced except in full, without written approval of the laboratory. The report must not be used by the client to claim product certification, approval, or endorsement by NVLAP, NIST, or any agency of the federal government. The Company reserves the right to dispose of all samples after a period of thirty (30) days, according to all state and federal guidelines, unless otherwise specified.

All components not quantified as asbestos content and non-asbestos content are considered to be non-fibrous matrix components. Matrix components may include, but are not limited to, gypsum, paint, silicate minerals, vinyl, binder, calcium carbonate, tar, and foam.

Inhomogeneous samples are separated into homogeneous subsamples and analyzed individually. ND means no fibers were detected. When detected, the minimum detection and reporting limit is less than 1% unless point counting is performed. Floor tile samples may contain large amounts of interference material and it is recommended that the sample be analyzed by gravimetric point count analysis to lower the detection limit and to aid in asbestos identification.

‡ A "Version" indicated by -"x" after the Lab ID# with a value greater than 1 indicates a sample with amended data. The revision number is

(866) 871-1984 www.eurofinsus.com/BuiltClient: Castle Hill Associates C/O: Mr. Brett Brumbaugh, REPA Re: Clarksburg VAMC; Renovate Pharmacy For

USD

Date of Sampling: 09-20-2024 Date of Receipt: 09-23-2024 Date of Report: 09-26-2024

ASBESTOS PLM REPORT

Location: 13, Black Tar on Wall Lab ID-Version‡: 18693791-1

Sample Layers Asbestos Content Black Tar ND Composite Non-Asbestos Content: 5% Cellulose Sample Composite Homogeneity: Good

Location: 14, 12" Tan FT Lab ID-Version‡: 18693792-1

Sample Layers Asbestos Content Tan Floor Tile ND Yellow Mastic ND White Thinset ND

Sample Composite Homogeneity: Moderate

Location: 15, 12" Tan FT Lab ID-Version‡: 18693793-1

Sample Layers Asbestos Content Tan Floor Tile ND Yellow Mastic ND White Thinset ND

Sample Composite Homogeneity: Moderate

Location: 16, Brown Cove Base Lab ID-Version‡: 18693794-1

Sample Layers Asbestos Content White Paper ND

Transparent Adhesive ND Brown Cove Base ND

Composite Non-Asbestos Content: 10% Cellulose Sample Composite Homogeneity: Moderate

EMLab ID: 3790025, Page 5 of 7Eurofins EPK Built Environment Testing, LLC

The test report shall not be reproduced except in full, without written approval of the laboratory. The report must not be used by the client to claim product certification, approval, or endorsement by NVLAP, NIST, or any agency of the federal government. The Company reserves the right to dispose of all samples after a period of thirty (30) days, according to all state and federal guidelines, unless otherwise specified.

All components not quantified as asbestos content and non-asbestos content are considered to be non-fibrous matrix components. Matrix components may include, but are not limited to, gypsum, paint, silicate minerals, vinyl, binder, calcium carbonate, tar, and foam.

Inhomogeneous samples are separated into homogeneous subsamples and analyzed individually. ND means no fibers were detected. When detected, the minimum detection and reporting limit is less than 1% unless point counting is performed. Floor tile samples may contain large amounts of interference material and it is recommended that the sample be analyzed by gravimetric point count analysis to lower the detection limit and to aid in asbestos identification.

‡ A "Version" indicated by -"x" after the Lab ID# with a value greater than 1 indicates a sample with amended data. The revision number is

(866) 871-1984 www.eurofinsus.com/BuiltClient: Castle Hill Associates C/O: Mr. Brett Brumbaugh, REPA Re: Clarksburg VAMC; Renovate Pharmacy For

USD

Date of Sampling: 09-20-2024 Date of Receipt: 09-23-2024 Date of Report: 09-26-2024

ASBESTOS PLM REPORT

Location: 17, Brown Cove Base Lab ID-Version‡: 18693795-1

Sample Layers Asbestos Content White Paper ND

Transparent Adhesive ND Brown Cove Base ND

Composite Non-Asbestos Content: 10% Cellulose Sample Composite Homogeneity: Moderate

Location: 18, Ceramic Tile Grout Lab ID-Version‡: 18693796-1

Sample Layers Asbestos Content White Grout ND

Sample Composite Homogeneity: Good

Location: 19, Ceramic Tile Grout Lab ID-Version‡: 18693797-1

Sample Layers Asbestos Content White Grout ND

Sample Composite Homogeneity: Good

Location: 20, 2x2 Ceiling Tile Lab ID-Version‡: 18693798-1

Sample Layers Asbestos Content Light Brown Ceiling Tile with White Surface ND

Composite Non-Asbestos Content: 50% Mineral Wool 40% Cellulose

Sample Composite Homogeneity: Good

EMLab ID: 3790025, Page 6 of 7Eurofins EPK Built Environment Testing, LLC

The test report shall not be reproduced except in full, without written approval of the laboratory. The report must not be used by the client to claim product certification, approval, or endorsement by NVLAP, NIST, or any agency of the federal government. The Company reserves the right to dispose of all samples after a period of thirty (30) days, according to all state and federal guidelines, unless otherwise specified.

All components not quantified as asbestos content and non-asbestos content are considered to be non-fibrous matrix components. Matrix components may include, but are not limited to, gypsum, paint, silicate minerals, vinyl, binder, calcium carbonate, tar, and foam.

Inhomogeneous samples are separated into homogeneous subsamples and analyzed individually. ND means no fibers were detected. When detected, the minimum detection and reporting limit is less than 1% unless point counting is performed. Floor tile samples may contain large amounts of interference material and it is recommended that the sample be analyzed by gravimetric point count analysis to lower the detection limit and to aid in asbestos identification.

‡ A "Version" indicated by -"x" after the Lab ID# with a value greater than 1 indicates a sample with amended data. The revision number is

(866) 871-1984 www.eurofinsus.com/BuiltClient: Castle Hill Associates C/O: Mr. Brett Brumbaugh, REPA Re: Clarksburg VAMC; Renovate Pharmacy For

USD

Date of Sampling: 09-20-2024 Date of Receipt: 09-23-2024 Date of Report: 09-26-2024

ASBESTOS PLM REPORT

Location: 21, 2x2 Ceiling Tile Lab ID-Version‡: 18693799-1

Sample Layers Asbestos Content Light Brown Ceiling Tile with White Surface ND

Composite Non-Asbestos Content: 50% Mineral Wool 40% Cellulose

Sample Composite Homogeneity: Good

Location: 22, Roof Vapor Barrier Tar Lab ID-Version‡: 18693800-1

Sample Layers Asbestos Content Black Vapor Barrier Tar ND

Sample Composite Homogeneity: Good

Location: 23, Roof Vapor Barrier Tar Lab ID-Version‡: 18693801-1

Sample Layers Asbestos Content Black Vapor Barrier Tar ND

Sample Composite Homogeneity: Good

EMLab ID: 3790025, Page 7 of 7Eurofins EPK Built Environment Testing, LLC

The test report shall not be reproduced except in full, without written approval of the laboratory. The report must not be used by the client to claim product certification, approval, or endorsement by NVLAP, NIST, or any agency of the federal government. The Company reserves the right to dispose of all samples after a period of thirty (30) days, according to all state and federal guidelines, unless otherwise specified.

All components not quantified as asbestos content and non-asbestos content are considered to be non-fibrous matrix components. Matrix components may include, but are not limited to, gypsum, paint, silicate minerals, vinyl, binder, calcium carbonate, tar, and foam.

Inhomogeneous samples are separated into homogeneous subsamples and analyzed individually. ND means no fibers were detected. When detected, the minimum detection and reporting limit is less than 1% unless point counting is performed. Floor tile samples may contain large amounts of interference material and it is recommended that the sample be analyzed by gravimetric point count analysis to lower the detection limit and to aid in asbestos identification.

‡ A "Version" indicated by -"x" after the Lab ID# with a value greater than 1 indicates a sample with amended data. The revision number is

INSPECTOR & LAB CERTIFICATIONS

INSPECTOR CERTIFICATIONS